Longitudinal disease burden and drug safety profiles of CFTR modulator therapy in cystic fibrosis: a real-world analysis from the NIH All of Us Research Program

Trikafta (elexacaftor/tezacaftor/ivacaftor) - Vertex

https://jcf-25-s2.elsevierdigitaledition.com/

C. Zeng 1; K. Raraigh 2; G. Cutting 2; J. Denny 3

Sep 9, 2026